WallStreetZenWallStreetZen
Analyst Ranking
Top 3%
#115 out of 4726 analysts
Average Return
+18.39%
Win Rate
47%91 out of 193
Risk vs Reward
Poor
Good

Jay Olson's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
89bio IncETNB
+578.03%$2.64$17.90
2022-05-13 -
2023-05-12
Buy
89bio IncETNB
+450.31%$3.22$17.72
2022-06-30 -
2023-06-29
Buy
Viking Therapeutics IncVKTX
+439.77%$15.44$83.34
2023-03-28 -
2024-03-27
Buy
Madrigal Pharmaceuticals IncMDGL
+365.01%$64.44$299.65
2022-05-10 -
2023-05-09
Buy
Prothena Corp Public Ltd CoPRTA
+357.12%$12.08$55.22
2020-07-09 -
2021-07-08
Buy

Jay Olson's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Biogen IncBIIB
20Buy$255.00+44.12%Maintains
6 days ago
Terns Pharmaceuticals IncTERN
1Buy$17.00+137.10%Initiates Coverage On
7 days ago
Sage Therapeutics IncSAGE
7Hold$8.00+34.68%Maintains
8 days ago
Incyte CorpINCY
10Buy$82.00+6.11%Maintains
8 days ago
Revolution Medicines IncRVMD
8Buy$60.00+5.73%Maintains
10 days ago
Madrigal Pharmaceuticals IncMDGL
8Buy$350.00+3.67%Maintains
15 days ago
Galecto IncGLTO
4Buy$10.00+45.77%Maintains
21 days ago
Viking Therapeutics IncVKTX
8Buy$138.00+113.52%Reiterates
a month ago
Marinus Pharmaceuticals IncMRNS
6Buy$6.00+1,751.85%Upgrades
a month ago
Prothena Corp Public Ltd CoPRTA
9Buy$62.00+267.30%Maintains
3 months ago
Gain Therapeutics IncGANX
1Buy$8.00+260.36%Assumes
3 months ago
Inovio Pharmaceuticals IncINO
1Buy$33.00+487.19%Maintains
3 months ago
Bicycle Therapeutics PLCBCYC
3Buy$48.00+104.17%Maintains
3 months ago
Amgen IncAMGN
17Buy$380.00+19.01%Maintains
3 months ago
Neurocrine Biosciences IncNBIX
12Buy$219.00+80.20%Maintains
3 months ago
Exelixis IncEXEL
4Buy$29.00-16.59%Maintains
3 months ago
Editas Medicine IncEDIT
6Hold$12.00+284.62%Maintains
5 months ago
Voyager Therapeutics IncVYGR
5Buy$18.00+170.68%Maintains
6 months ago
Sutro Biopharma IncSTRO
5Buy$10.00+160.42%Maintains
6 months ago
Crispr Therapeutics AgCRSP
6Buy$95.00+88.64%Maintains
6 months ago
Acadia Pharmaceuticals IncACAD
11Hold$19.00+26.67%Maintains
6 months ago
Skye Bioscience IncSKYE
1Buy$25.00+367.29%Initiates Coverage On
7 months ago
Q32 Bio IncQTTB
1Buy$50.00+4.78%Initiates Coverage On
7 months ago
Ionis Pharmaceuticals IncIONS
3Buy$75.00+93.30%Maintains
7 months ago
Cognition Therapeutics IncCGTX
4Buy$9.00+1,744.26%Maintains
7 months ago
Jasper Therapeutics IncJSPR
4Buy$80.00+257.14%Maintains
8 months ago
Immuneering CorpIMRX
1Buy$25.00+1,175.51%Reiterates
8 months ago
Biovie IncBIVI
4Buy$50.00+1,961.86%Maintains
a year ago
Enanta Pharmaceuticals IncENTA
7Hold$21.00+86.50%Maintains
a year ago
Intellia Therapeutics IncNTLA
7Buy$70.00+353.66%Maintains
a year ago
Immunogen IncIMGN
1Hold$16.00N/AInitiates Coverage On
a year ago
Mirati Therapeutics IncMRTX
7Buy$62.00N/AMaintains
a year ago
Denali Therapeutics IncDNLI
3Buy$68.00N/AMaintains
a year ago
Cymabay Therapeutics IncCBAY
3Buy$16.00N/AMaintains
a year ago
89bio IncETNB
4Buy$30.00N/AReiterates
a year ago
Karuna Therapeutics IncKRTX
4Buy$280.00N/AReiterates
a year ago
Seagen IncSGEN
8Buy$229.00N/AMaintains
2 years ago
Nektar TherapeuticsNKTR
2Hold$3.00N/AMaintains
2 years ago
Cincor Pharma IncCINC
3HoldN/AN/ADowngrades
2 years ago
Ayala Pharmaceuticals IncAYLA
4HoldN/AN/ADowngrades
2 years ago
Relmada Therapeutics IncRLMD
2HoldN/AN/ADowngrades
2 years ago
Sierra Oncology IncSRRA
2Hold$55.00N/ADowngrades
3 years ago
Focus Financial Partners IncFOCS
1Buy$71.00N/AMaintains
3 years ago
Korro Bio IncKRRO
2Buy$20.00N/AMaintains
4 years ago
Intercept Pharmaceuticals IncICPT
1Hold$46.00N/ADowngrades
4 years ago
Tempest Therapeutics IncTPST
1Hold$2.00N/ADowngrades
5 years ago
Mediwound LtdMDWD
1Buy$84.00N/AMaintains
7 years ago
Acorda Therapeutics IncACORQ
2Hold$2,520.00N/AMaintains
7 years ago
Medicines CoMDCO
2BuyN/AN/AUpgrades
7 years ago
Neuroderm LtdNDRM
2Buy$42.00N/AUpgrades
7 years ago
Therapeuticsmd IncTXMD
1HoldN/AN/ADowngrades
7 years ago
Portola Pharmaceuticals IncPTLA
1BuyN/AN/AUpgrades
8 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.